Comparison of PET/CT-based eligibility according to VISION and TheraP trial criteria in end-stage prostate cancer patients undergoing radioligand therapy Kerstin MichalskiAleksander KosmalaPhilipp E. Hartrampf Original Article Open access 27 October 2023 Pages: 87 - 95
Difference in arterial FDG accumulation in healthy study participants between digital PET/CT and standard PET/CT Noriko NittaRika YoshimatsuTakuji Yamagami Original Article 18 October 2023 Pages: 96 - 102
A prospective study of 68Ga-PSMA PET/CT imaging of HCC as diagnosed on conventional imaging to evaluate for potential 177Lu-PSMA therapy Shamim Ahmed ShamimNaresh KumarChandrasekhar Bal Original Article 06 November 2023 Pages: 103 - 111
High efficacy of particle beam therapies against tumors under hypoxia and prediction of the early stage treatment effect using 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography Akira MakinoKyo KumeYasushi Kiyono Original Article Open access 19 October 2023 Pages: 112 - 119
[18F]-FDG uptake in brain slices prepared from an aged mouse model of Alzheimer’s disease using a dynamic autoradiography technique Hiroko MaruyamaMisaki GomiToru Sasaki Original Article 03 November 2023 Pages: 120 - 130
Comparative study of physiological FDG uptake in small structures between silicon photomultiplier-based PET and conventional PET Shiro WatanabeKenji HirataKohsuke Kudo Original Article 09 November 2023 Pages: 131 - 138
99mTc(CO)3-labeled 1-(2-Pyridyl)piperazine derivatives as radioligands for 5-HT7 receptors Alireza MardanshahiSamaneh VaseghiSajjad Molavipordanjani Original Article 30 November 2023 Pages: 139 - 153
Visualization of small brain nuclei with a high-spatial resolution, clinically available whole-body PET scanner Yuki ShinoharaMasanobu IbarakiToshibumi Kinoshita Original Article Open access 21 November 2023 Pages: 154 - 161
